JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The value of Optos Panoramic 200MA imaging for the monitoring of large suspicious choroidal lesions.

PURPOSE: Suspicious elevated choroidal lesions require close monitoring for potential malignant transformation. We describe a case of a large choroidal lesion in which conventional digital photography was not optimal for documenting baseline clinical features. The Optos Panoramic 200MA system documented the lesion in its entirety.

DESIGN: Observational case report.

METHOD: A 75 year old female presented with decreased vision and a large pigmented choroidal lesion (> 10 mm in diameter).

RESULT: Standard 30 degree fundus photography yielded poor images due to the large size of the lesion and media opacity from cataract. The Optos system allowed for the entire lesion to be readily captured in a single photograph for serial evaluations over time.

CONCLUSION: Large dimension choroidal lesions of the fundus may be more easily and accurately documented with Optos ultrawide-field imaging.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app